World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03152006
Date of registration: 09/05/2017
Prospective Registration: Yes
Primary sponsor: University of Nevada, Las Vegas
Public title: Adolescent Coordinated Transition Nigerian HIV+ Youth ACT
Scientific title: Adolescent Coordinated Transition (ACT) to Improve Health Outcomes Among Nigerian HIV+ Youth
Date of first enrolment: June 28, 2017
Target sample size: 216
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03152006
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Nigeria
Contacts
Name:     Echezona Ezeanolue, MD, MPH
Address: 
Telephone: 702-895-2687
Email: echezona.ezeanolue@unlv.edu
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Documented HIV infection

- Aware of HIV diagnosis

- Currently on ART

Exclusion Criteria:

- Medically unstable



Age minimum: 13 Years
Age maximum: 17 Years
Gender: All
Health Condition(s) or Problem(s) studied
HIV/AIDS
Intervention(s)
Other: ACT
Primary Outcome(s)
Retention in care 24 months post-transfer [Time Frame: 24 months]
Retention in care in care 6 months post-transfer [Time Frame: 6 months]
Retention in care 12 months post-transfer [Time Frame: 12 months]
Secondary Outcome(s)
Transition Readiness [Time Frame: Enrollment, baseline (12 months), 24 and 36 months]
Mental Health and Wellbeing [Time Frame: Enrollment, baseline (12 months), 24 and 36 months]
Social Support [Time Frame: Enrollment, baseline (12 months), 24 and 36 months]
Sexual Risk Behavior [Time Frame: Enrollment, baseline (12 months), 24 and 36 months]
Health Locus of Control [Time Frame: Enrollment, baseline (12 months), 24 and 36 months]
Viral Suppression [Time Frame: Enrollment, baseline (12 months), 24 and 36 months]
Secondary ID(s)
990070-4
R01HD089871
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history